Form 4 for OM Outset Medical, Inc.
Accepted 2021-09-01 00:00:00 ET · period of report 2021-09-01 · accession 0001484612-21-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-09-01 | 2021-09-01 | OM | Vazquez Martin | COO | S - Sale+OE | $49.17 | -5,000 | 9,255 | -35% | -$245.8K |
| D | 2021-09-01 | 2021-09-01 | OM | Vazquez Martin | COO | M - OptEx | $3.88 | +5,000 | 14.3K | +54% | +$19.4K |
| D | 2021-09-01 | 2021-09-01 | OM | Vazquez Martin | COO | M - OptEx | $0.00 | -5,000 | 58.5K | -8% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-09-01 | S | D | 5,000 | $49.17 | 9,255 | D | — | — | (F2) The price reported in Column 4 is a weighted average price. The shares of common stock of the Issuer were sold in multiple transactions at prices ranging from $48.62 to $49.73, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2021-09-01 | M | A | 5,000 | $3.88 | 14,255 | D | — | — | |
| 3 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-09-01 | M | D | 5,000 | $0.00 | 58,489 | D | $3.88 · — to 2027-12-19 | 5,000 Common Stock | (F3) This option vests 25% on October 9, 2018 and then in 36 equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting date. |